Pharmaceutical Competitive Intelligence Excellence

Optimizing Data Collection within Approved Guidelines

Publication Date	April 2008
Publisher	Best Practices
Product Type	Report
Pages	56
ISBN Number	not applicable
Product Code	BPC00033

Buy this product or for assistance call +44 20 7060 7474

PDF £2,400.00$3992 | €2686

PRINT £2,400.00$3992 | €2686

FAX Order above formats by FAX

Summary

Research Overview

Data for this study were conducted in an online survey instrument and through eight in-depth interviews with CI leaders and practitioners.

Study Objective and Methodology

The objective of this benchmarking study is to understand how U.S. pharmaceutical and biotechnology organizations can optimize their CI operations while working within defined guidelines.

Particular attention will be paid to CI information sources, what is being collected, and how CI groups work with legal groups to develop standard operating procedures for data collection that are in the best interests of the organization as a whole and to maximize the CI department's ability to deliver results.

Key Study Objectives

Define range of useful and effective information sources
Understand roles and mechanisms of data collection, assimilation, analysis, and dissemination
Delineate the process of CI guideline development
Provide examples of CI guidelines and how they are used
Explore effective CI practices
Describe best practices in developing and managing the CI function

Key Findings

Multiple Sources Are Vital to Effective Ci

Triangulate from multiple data sources to develop the most accurate projections
Critical types of secondary sources range from trade publications to investor feeds
Integrate primary data with these "existing" sources

People, Processes and Use of Third Party Vendors are Keys to Optimizing Data Collection

Hire the right people, utilize advanced Internet search techniques, collect and review data overtime to distill relevant, actionable information
Talk with employees across functions inside your company to discover information gaps
Involve legal to mitigate risk if internal employees gather external CI information
All large - and most small - pharma companies use vendors to minimize risk, to avoid the perception of wrongdoing, to improve the process, and get better finished intelligence
Develop clear processes, practices and guidelines for all critical activities, such as collecting CI at trade shows

Content

Research Overview
Benchmark Class
Study Perspective
Scope of Benchmark Class
Definitions
Key Findings and Insights
Data Sources
- Multiple Sources are Vital to Effective CI
- Must-Haves and Effective Secondary Sources
- Small Pharma Relies Heavily on Secondary Sources
- Large Pharma Rates Primary about Secondary Sources
Optimizing Data Collection - People
- People and Processes are Keys to Optimizing Data Collection
- Profile of the Best CI Employee: Spotlight
Optimizing Data Collection - Processes
- Tap Internal Sources First
- Vendors Collect Majority of Primary CI Data
- Most Small Pharma Employ Primary CI Research Vendors
- Large Pharma Outsource Primary CI Research to Vendors
- Holding Vendors to Strict Standards
- Vendors Say They Do Not Misrepresent
- Involve Legal to Decrease Risk
Optimizing Data Collection - Practices
- Employees across Functions Gather Data Points
- Rich Conversations Stem from Effective Elicitation
- Take the Team Approach at Conferences
- Information about Pipeline Products is Sought and Valued more highly
- Corporate Strategy Proves to be Useful Data Point
Development and Examples of Ci Guidelines
- Best Practices for Developing CI Guidelines
- Formal and Informal Policies Govern CI Operations
- Guidelines Encompass Ethics Code, SCIP Policies & Laws
- CI Guidelines Include Specific Policies & Procedures
- Prescribed Policies Govern Primary Data Collection
- General versus Prescribed CI Policies: Spotlight
- Legal Creates Guidelines for Small Pharma
- Legal and CI Work Collaboratively in Large Pharma
- Creating CI Guidelines with Legal: Spotlight
- CI Guidelines Enable Success
- Train CI & Non-CI Employees on Guidelines
- Effectively Train on the Guidelines: Spotlight
- Executives Show Limited Support for Risky CI Practices
Managing Expectations
- Manage Expectations up Front
- Educate the Requestor and Protect the Company
Rapid Response Team
- CI Plays Pivotal Role in Rapid Response Situations
Building A Successful Ci Function
- CI Executives Advise Emerging CI Functions to Evolve
about Best Practices, Llc
List of Tables
- Table of Contents